@lab_ernst

The Cancer & Inflammation Laboratory @ONJCRI led by Prof. Matthias Ernst | Exploring novel ways to target communication between tumour & normal cells in #cancer

 Melbourne, Victoria
onjcri.org.au/our-research/cancer-and-inflammation-laboratory/
Joined April 2022
  • Tweets37
  • Following95
  • Followers138
3Media
📢 New Publication 📢 We are thrilled to announce a new publication in @CellReports, led by Drs. Moritz Eissmann @EissmannMo95094, Anne Huber, and Amr Allam @The__Sci! This study investigated the roles of KRAS, PI3K, and TP53 mutations in gastric cancer progression Read more👇
2
3
15
509
Yesterday's first stop at 32km at Jamieson, 91km/day 1 safely completed. 230km to go Everybody is happy and (still) pumped. VIC discovery tour 2023 @tourdecure_aus supporting cancer research @ONJCRI Your support is greatly appreciated! Link to donate: protect-au.mimecast.com/s/XB…
11
434
Deeply saddened by the loss of Olivia. A beacon of hope to many impacted by cancer; her enthusiasm for life outweighed any challenges she faced. I'll always treasure our time together @ONJCRI, & the positivity & grace that came with her presence. We miss you Olivia, love & light.
ONJ Cancer Research Institute@ONJCRI9 Aug 2022
We are deeply saddened to learn of Dame Olivia Newton-John’s tragic passing overnight. As our Founding Champion, Olivia has been a source of inspiration to many, including the dedicated research team at the ONJCRI. Our thoughts are with Olivia’s family and friends at this time.
16
Vale Olivia and thank you for your love & support! @olivianj Olivia was a tireless advocate for Cancer care, research and patient wellness. Here are some scenes from the history of the @ONJCancerCentre @ONJCRI instagram.com/p/ChBfQzKps_w/…

Jonathan Cebon (@jonathancebon) • Instagram photos and videos

instagram.com
4
1
29
‘Ahead of her time’: How Olivia Newton-John used star power to help others theage.com.au/national/victo…

‘Ahead of her time’: How Olivia Newton-John used star power to help others

By being open about her metastatic breast cancer diagnosis, she helped break down misconceptions about the disease.

theage.com.au
8
25
Thanks to the @NBCFAus for funding this important research. #breastcancer @ONJCRI
ONJ Cancer Research Institute@ONJCRI25 Jul 2022
A new ONJCRI study, supported by the National Breast Cancer Foundation, is exploring how existing drugs that are used to treat other diseases like leukaemia and rheumatoid arthritis, could overcome inflammatory breast cancer tumours. protect-au.mimecast.com/s/fI… #breastcancer #NBCF
14
The true legacy of Gregor Mendel: careful, rigorous and humble science nature.com/articles/d41586-0…
1
3
Great to welcome the Australian Federal Assistant Minister for Health & Aged Care, @gedkearney , & CEO of @ocrfaustralia, @LucindaJNolan1, for a visit & tour of the labs at the @ONJCRI. We appreciate your support & enthusiasm of our medical researchers & #cancer research.
21
Dr Lisa Mielke from @ONJCRI @latrobe is interested in whether T cells in the intra-epithelial layers of the gut are unique.
1
8
Thanks to our wonderful supporters. Fabulous to have so many face-to-face and remote participants!
1
9
Dr. Kellie Mouchemore presenting her talk on myeloid cell heterogeneity in breast cancer at MIN Reconnect Symposium. @WEHI_research @MelbImmunoNet
1
9
Dr. Lisa Mielke presenting her talk “TCF-1 is a potent checkpoint in colorectal cancer tumour immunity” at MIN Reconnect Symposium. @Mielke_Lisa @MelbImmunoNet @WEHI_research
1
14
Dr. Ajith Vasanthakumar presents his talk on targeting tissue resident Tregs for cancer immunotherapy at the MIN Reconnect Symposium. @ajithvasanthan @WEHI_research @MelbImmunoNet
2
24
Next we have @dmellorhynelle from @lab_ernst @ONJCRI presenting her work on STAT3 inhibitors of chemotherapy #LIMSFS22 @LIMSLTU
3
9
Our first speaker of the day is Moritz from @lab_ernst @ONJCRI speaking about STAT3 signalling in cancer! #LIMSFS22 @LIMSLTU
2
8
Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to #immunotherapy @AshleighRPoh @lab_ernst @ONJCRI @GICancer @ScienceAdvances @Innov_Medicine #CancerResearch #immunology #health #MedTwitter science.org/doi/10.1126/scia…

Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves...

HCK inhibition boosts response to immunotherapy by stimulating myeloid cells and enhancing T cell recruitment and activation.

science.org
1
2
Congrats @AshleighRPoh @lab_ernst @ONJCRI and all involved. So good to see this out! @ScienceAdvances – at Melbourne, Victoria
9
7
1
69
Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy. Congratulations ⁦@AshleighRPoh⁩ ⁦@lab_ernst⁩ ⁦@ONJCRI⁩ ⁦@GICancer⁩ science.org/doi/10.1126/scia…

Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves...

HCK inhibition boosts response to immunotherapy by stimulating myeloid cells and enhancing T cell recruitment and activation.

science.org
1
2
Led by Dr. @AshleighRPoh, Dr. Matthias Ernst's group (@lab_ernst) at @ONJCRI suggests that targeting HCK activity enhances response to #immunotherapy by stimulating immune cell activation and inhibiting the immunosuppressive tumor #microenvironment. 📝 bit.ly/3yfDrPe
2
18
Load more